Haoxi Health Technology Limited HAO

2.90 (0.07) (2.36%) as of 25 Sep
Market cap
$1.8M
P/E
—
Insider Buys alert about insiders buying in the last 12 month
Jun '21 Dec '21 Jun '22 Dec '22 Jun '23 Jun '24 Jun '25
P/FCF ratio
0.00 0.00 0.00 — 0.00 0.00 0.00
P/Operating CF
0.00 0.00 0.00 — 0.00 0.00 0.00
P/B ratio
0.00 0.00 0.00 — 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/Sales
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/EBITDA
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/Operating CF
0.00 0.00 0.00 — 0.00 2.77 1.11
EV/FCF
0.00 0.00 0.00 — 0.00 2.60 1.09
Quick Ratio
0.15 0.15 0.15 0.00 0.47 1.78 2.34
Current Ratio
0.22 0.22 0.22 0.00 1.43 3.98 5.05
Net Debt/EBITDA
(1.09) (1.09) 0.54 (0.31) (0.37) (3.20) 4.12
Debt/Assets
0.00% 0.00% 80.92% 3,235.06% 17.04% 7.32% 8.87%
Debt/Equity
0.00 0.00 (0.30) 0.00 0.49 0.10 0.11
Asset Turnover
0.00 29.75 29.75 0.00 12.63 4.86 1.77
Operating CF/Net income
0.00 0.00 (2.76) 0.00 (0.90) (0.58) (0.87)
Capex/Depreciation
— — (3.95) — (5.42) (5.23) (5.59)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
0.00% (15.90%) (16.29%) 0.00% 1,924.21% 20.12% 27.06%
ROA
0.00% 45.05% 45.05% 352.21% 43.37% 12.94% 20.90%
ROIC
0.00% 0.00% 0.00% (202.75%) 66.50% 18.66% (11.71%)
Return on Tangible Assets
(15.74%) (15.74%) (15.74%) 12,594.81% 78.12% 11.10% 24.49%
Average Days of Receivables
0.09 0.09 0.09 0.00 0.10 1.71 5.12
Research and Development Expense of Revenue
0.63% 0.63% 0.63% — 0.21% 0.16% 0.24%
Selling, General and Administrative Expense of Revenue
1.72% 1.72% 1.72% 0.00% 2.86% 1.96% 8.68%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.08
Share Based Compensation of Revenue
0.00% 0.00% 0.00% — 0.00% 0.00% 0.18%
Graham Net Nets
0.00 0.00 0.00 — 0.00 0.00 0.00
Graham Number
0.00 0.00 0.00 — 0.00 0.00 0.00
Free Cash Flow Yield
0.00% 0.00% 0.00% — 0.00% 0.00% 0.00%
Revenue per Share
0.00 0.00 40,392.25 — 70,573.00 97,039.60 36,449.22
Operating CF per Share
— — (1,688.50) — (2,180.25) (1,495.20) (3,731.22)
Capex per Share
— — (21.75) — (113.75) (110.80) (2,311.11)
Free Cash Flow per Share
— — (1,710.25) — (2,294.00) (1,606.00) (6,042.33)
Cash per Share
0.00 0.00 733.75 — 3,008.00 13,311.40 9,576.11
Shareholders Equity per Share
0.00 0.00 (3,664.25) — 3,916.25 22,544.00 19,307.11
Interest Debt per Share
— — 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.00 0.00 (3,664.25) — 3,916.25 22,544.00 19,307.11
Free Cash Flow
— — (0.68) — (0.92) (0.80) (5.44)
Working Capital
(1.56) (1.56) (1.56) 0.01 1.10 11.51 15.72
Capital Expenditures
— — (0.01) — (0.05) (0.06) (2.08)
Net Current Asset Value
(1.56) (1.56) (1.56) (0.24) 0.78 11.15 15.39
EV/EBIT
0.00 0.00 0.00 — 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 — 0.00 0.00 0.06
Net Profit Margin
1.51% 1.51% 1.51% 0.00% 3.44% 2.66% 11.82%
Other line items
Depreciation/Fixed assets
0.00 0.00 0.23 — 0.06 0.08 3.41
Cash ROIC
0.80% 0.80% 93.45% 0.00% (28.78%) (4.59%) (12.42%)
Accounts Receivable Turnover
0.00 4,142.79 4,142.79 0.00 3,666.13 413.99 95.50
Accounts Payable Turnover
0.00 0.00 0.00 — 39.46 129.22 78.94
Inventory Turnover
0.00 0.00 0.00 — 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 29.93 — 0.76 5.21 1.76
Days of Inventory on Hand
0.00 0.00 0.00 — 0.00 0.00 0.00
Average Receivables
— 0.00 0.00 0.01 0.01 0.12 0.34
Average Payables
— — — — 0.66 0.35 0.40
Average Assets
— 0.54 0.54 0.28 2.24 9.99 18.55
Average Common Equity
— (1.54) (1.50) — 0.05 6.42 14.32

Fold the line items

Columns are period end dates